NO20031911D0 - Inhalation solution formulation with a tiotropium salt - Google Patents

Inhalation solution formulation with a tiotropium salt

Info

Publication number: NO20031911D0
Authority: NO; Norway
Prior art keywords: solution formulation; inhalation solution; tiotropium salt; tiotropium; salt
Prior art date: 2000-10-31

Application number

NO20031911A

Other languages

Norwegian (no)

Other versions

NO20031911L (en

NO332519B1 (en

Inventor

Barbara Niklaus-Humke

Christel Schmelzer

Petra Barth

Karin Drechsel

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-10-31

Filing date

2003-04-29

Publication date

2003-04-29

2003-04-29 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2003-04-29 Publication of NO20031911L publication Critical patent/NO20031911L/en

2003-04-29 Publication of NO20031911D0 publication Critical patent/NO20031911D0/en

2012-10-08 Publication of NO332519B1 publication Critical patent/NO332519B1/en

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, ***e
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/537—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines spiro-condensed or forming part of bridged ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pulmonology (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Dispersion Chemistry (AREA)
Otolaryngology (AREA)
Emergency Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Cosmetics (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

NO20031911A 2000-10-31 2003-04-29 Inhalation solution formulation with a tiotropium salt, process for the preparation thereof and such formulations for the treatment of disease NO332519B1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
DE10054036		2000-10-31
PCT/EP2001/012292 WO2002036104A2 (en)	2000-10-31	2001-10-24	Inhalative solution formulation containing a tiotropium salt

Publications (3)

Publication Number	Publication Date
NO20031911L NO20031911L (en)	2003-04-29
NO20031911D0 true NO20031911D0 (en)	2003-04-29
NO332519B1 NO332519B1 (en)	2012-10-08

Family

ID=7661723

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20031911A NO332519B1 (en)	2000-10-31	2003-04-29	Inhalation solution formulation with a tiotropium salt, process for the preparation thereof and such formulations for the treatment of disease

Country Status (39)

Country	Link
EP (2)	EP1837021A3 (en)
JP (1)	JP4344135B2 (en)
KR (1)	KR100853107B1 (en)
CN (2)	CN100396285C (en)
AR (1)	AR038764A1 (en)
AT (1)	ATE373473T1 (en)
AU (2)	AU2173802A (en)
BG (1)	BG66315B1 (en)
BR (1)	BRPI0115076B8 (en)
CA (1)	CA2426074C (en)
CY (1)	CY1107825T1 (en)
CZ (1)	CZ300794B6 (en)
DE (2)	DE10152521A1 (en)
DK (1)	DK1333819T3 (en)
EA (1)	EA007604B1 (en)
EC (1)	ECSP034541A (en)
EE (1)	EE05314B1 (en)
ES (1)	ES2294045T3 (en)
HK (1)	HK1060524A1 (en)
HR (1)	HRP20030338B1 (en)
HU (1)	HU229411B1 (en)
IL (2)	IL155538A0 (en)
ME (1)	ME00244B (en)
MX (1)	MXPA03003742A (en)
MY (1)	MY138940A (en)
NO (1)	NO332519B1 (en)
NZ (1)	NZ526023A (en)
PE (1)	PE20030092A1 (en)
PL (1)	PL203316B1 (en)
PT (1)	PT1333819E (en)
RS (1)	RS50859B (en)
SA (1)	SA01220482B1 (en)
SI (1)	SI1333819T1 (en)
SK (1)	SK286027B6 (en)
TW (1)	TWI293885B (en)
UA (1)	UA78690C2 (en)
UY (1)	UY26989A1 (en)
WO (1)	WO2002036104A2 (en)
ZA (1)	ZA200302922B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE10216036A1 (en) *	2002-04-11	2003-10-23	Boehringer Ingelheim Pharma	Aerosol formulation for inhalation containing a tiotropium salt
CN1292748C (en) *	2003-03-05	2007-01-03	南昌弘益科技有限公司	Timepidium bromide inhalant powders and their preparing process
PT1682541E (en)	2003-11-03	2010-04-14	Boehringer Ingelheim Int	Method for producing tiotropium salts
UY28589A1 (en) *	2003-11-03	2005-06-30	Boehringer Ingelheim Int	NEW TIOTROPE SALTS, PROCEDURES FOR PREPARATION, AS WELL AS MEDICINAL FORMULATIONS CONTAINING THEM
ES2393794T3 (en)	2005-05-02	2012-12-28	Boehringer Ingelheim International Gmbh	New crystalline forms of tiotropium bromide
EP2044967A1 (en) *	2007-10-01	2009-04-08	Boehringer Ingelheim Pharma GmbH & Co. KG	Atomiser
CN104306361A (en) *	2014-09-24	2015-01-28	万特制药(海南)有限公司	Tiotropium bromide-containing inhalable solution
CN111374963A (en) *	2018-12-31	2020-07-07	天津药业研究院有限公司	Tiotropium solution for inhalation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3931041C2 (en) *	1989-09-16	2000-04-06	Boehringer Ingelheim Kg	Esters of thienyl carboxylic acids with amino alcohols, their quaternization products, processes for their preparation and medicaments containing them
SG45171A1 (en) *	1990-03-21	1998-01-16	Boehringer Ingelheim Int	Atomising devices and methods
DE19536902A1 (en) *	1995-10-04	1997-04-10	Boehringer Ingelheim Int	Miniature fluid pressure generating device
DE19653969A1 (en) *	1996-12-20	1998-06-25	Boehringer Ingelheim Kg	New aqueous pharmaceutical preparation for the production of propellant-free aerosols
DE19847968A1 (en) *	1998-10-17	2000-04-20	Boehringer Ingelheim Pharma	Separate storage of an active material and a solvent comprises a closure cap and a container, with a chamber attached to the unit.

2001
- 2001-10-24 BR BRPI0115076A patent/BRPI0115076B8/en not_active IP Right Cessation
- 2001-10-24 DE DE10152521A patent/DE10152521A1/en not_active Withdrawn
- 2001-10-24 ME MEP-2008-404A patent/ME00244B/en unknown
- 2001-10-24 ES ES01992567T patent/ES2294045T3/en not_active Expired - Lifetime
- 2001-10-24 EA EA200300482A patent/EA007604B1/en not_active IP Right Cessation
- 2001-10-24 DK DK01992567T patent/DK1333819T3/en active
- 2001-10-24 IL IL15553801A patent/IL155538A0/en active IP Right Grant
- 2001-10-24 AT AT01992567T patent/ATE373473T1/en active
- 2001-10-24 AU AU2173802A patent/AU2173802A/en active Pending
- 2001-10-24 EP EP07111499A patent/EP1837021A3/en not_active Withdrawn
- 2001-10-24 EE EEP200300203A patent/EE05314B1/en unknown
- 2001-10-24 PL PL360405A patent/PL203316B1/en unknown
- 2001-10-24 RS YUP-330/03A patent/RS50859B/en unknown
- 2001-10-24 DE DE50113037T patent/DE50113037D1/en not_active Expired - Lifetime
- 2001-10-24 WO PCT/EP2001/012292 patent/WO2002036104A2/en active IP Right Grant
- 2001-10-24 EP EP01992567A patent/EP1333819B1/en not_active Expired - Lifetime
- 2001-10-24 PT PT01992567T patent/PT1333819E/en unknown
- 2001-10-24 CA CA002426074A patent/CA2426074C/en not_active Expired - Fee Related
- 2001-10-24 UA UA2003054959A patent/UA78690C2/en unknown
- 2001-10-24 NZ NZ526023A patent/NZ526023A/en not_active IP Right Cessation
- 2001-10-24 SI SI200130774T patent/SI1333819T1/en unknown
- 2001-10-24 JP JP2002538916A patent/JP4344135B2/en not_active Expired - Lifetime
- 2001-10-24 KR KR1020037006013A patent/KR100853107B1/en active IP Right Grant
- 2001-10-24 CN CNB018183158A patent/CN100396285C/en not_active Expired - Lifetime
- 2001-10-24 MX MXPA03003742A patent/MXPA03003742A/en active IP Right Grant
- 2001-10-24 SK SK527-2003A patent/SK286027B6/en not_active IP Right Cessation
- 2001-10-24 HU HU0301378A patent/HU229411B1/en unknown
- 2001-10-24 AU AU2002221738A patent/AU2002221738B2/en not_active Expired
- 2001-10-24 CZ CZ20031486A patent/CZ300794B6/en unknown
- 2001-10-24 CN CNA2008100985489A patent/CN101292964A/en active Pending
- 2001-10-28 SA SA01220482A patent/SA01220482B1/en unknown
- 2001-10-29 MY MYPI20015000A patent/MY138940A/en unknown
- 2001-10-29 TW TW090126764A patent/TWI293885B/en active
- 2001-10-29 UY UY26989A patent/UY26989A1/en not_active Application Discontinuation
- 2001-10-31 PE PE2001001086A patent/PE20030092A1/en not_active Application Discontinuation
- 2001-10-31 AR ARP010105087A patent/AR038764A1/en not_active Ceased/Invalidation/Refusal/Rejection/Nullification
2003
- 2003-04-07 EC EC2003004541A patent/ECSP034541A/en unknown
- 2003-04-14 ZA ZA200302922A patent/ZA200302922B/en unknown
- 2003-04-16 BG BG107727A patent/BG66315B1/en active Active
- 2003-04-21 IL IL155538A patent/IL155538A/en unknown
- 2003-04-28 HR HR20030338A patent/HRP20030338B1/en not_active IP Right Cessation
- 2003-04-29 NO NO20031911A patent/NO332519B1/en not_active IP Right Cessation
2004
- 2004-05-20 HK HK04103586A patent/HK1060524A1/en not_active IP Right Cessation
2007
- 2007-12-07 CY CY20071101562T patent/CY1107825T1/en unknown

Also Published As

Publication number	Publication date
EA007604B1 (en)	2006-12-29
ES2294045T3 (en)	2008-04-01
EA200300482A1 (en)	2003-12-25
KR20030060926A (en)	2003-07-16
WO2002036104A3 (en)	2002-08-01
CN101292964A (en)	2008-10-29
IL155538A (en)	2008-11-26
ECSP034541A (en)	2003-05-26
BG107727A (en)	2004-11-30
CN1473038A (en)	2004-02-04
MY138940A (en)	2009-08-28
PT1333819E (en)	2007-10-29
EE200300203A (en)	2003-10-15
EP1333819B1 (en)	2007-09-19
NO20031911L (en)	2003-04-29
SK286027B6 (en)	2008-01-07
YU33003A (en)	2006-05-25
PE20030092A1 (en)	2003-03-24
JP4344135B2 (en)	2009-10-14
BG66315B1 (en)	2013-04-30
WO2002036104A2 (en)	2002-05-10
RS50859B (en)	2010-08-31
NO332519B1 (en)	2012-10-08
KR100853107B1 (en)	2008-08-21
EP1837021A3 (en)	2008-03-19
MXPA03003742A (en)	2004-10-15
DE10152521A1 (en)	2002-07-11
ZA200302922B (en)	2004-04-22
NZ526023A (en)	2005-05-27
CY1107825T1 (en)	2013-06-19
CZ300794B6 (en)	2009-08-12
CZ20031486A3 (en)	2003-08-13
SA01220482B1 (en)	2007-07-31
SK5272003A3 (en)	2003-10-07
AU2002221738B2 (en)	2007-01-11
TWI293885B (en)	2008-03-01
HK1060524A1 (en)	2004-08-13
UA78690C2 (en)	2007-04-25
AU2173802A (en)	2002-05-15
HRP20030338B1 (en)	2011-09-30
BR0115076A (en)	2003-07-29
AR038764A1 (en)	2005-01-26
EP1333819A2 (en)	2003-08-13
MEP40408A (en)	2011-02-10
HUP0301378A3 (en)	2005-12-28
BRPI0115076B1 (en)	2016-07-26
ME00244B (en)	2011-05-10
JP2004512357A (en)	2004-04-22
PL203316B1 (en)	2009-09-30
ATE373473T1 (en)	2007-10-15
HUP0301378A2 (en)	2003-10-28
IL155538A0 (en)	2003-11-23
HRP20030338A2 (en)	2005-04-30
CA2426074C (en)	2008-12-23
DE50113037D1 (en)	2007-10-31
UY26989A1 (en)	2002-06-20
PL360405A1 (en)	2004-09-06
CA2426074A1 (en)	2002-05-10
EP1837021A2 (en)	2007-09-26
SI1333819T1 (en)	2007-12-31
HU229411B1 (en)	2013-12-30
EE05314B1 (en)	2010-08-16
DK1333819T3 (en)	2007-12-03
CN100396285C (en)	2008-06-25
BRPI0115076B8 (en)	2021-05-25

Legal Events

Date	Code	Title	Description
2021-11-08	MK1K	Patent expired

Publication	Publication Date	Title
NO2020007I1 (en)	2020-03-19	Sitagliptin, optionally in the form of a pharmaceutically acceptable salt
NO2020019I1 (en)	2020-06-30	Maraviroc optionally in the form of a pharmaceutically acceptable salt
EE200200428A (en)	2003-02-17	Innovative inhalation powder containing tiotropium
DE60141149D1 (en)	2010-03-11	Medical inhalation device
NO20022922D0 (en)	2002-06-18	Inhalation
SE0302578L (en)	2003-12-02	Absorbent insert for use with an outer absorbent garment
DK1313714T3 (en)	2008-12-15	Valsartan salts
DE60130156D1 (en)	2007-10-04	inhaler
NO20032909D0 (en)	2003-06-24	Glucopyranosyloxypyrazole derivatives as well as their drug use
DE50100715D1 (en)	2003-11-06	inhalation nebulizer
DK1299095T3 (en)	2004-10-11	Clear aqueous anesthetic preparation
EE200200568A (en)	2004-06-15	Therapeutic diphenylether compounds
NO20022921D0 (en)	2002-06-18	Inhalation
NO20031914L (en)	2003-06-23	Inhalable solution formulation containing a tiotropium salt
NO20031911D0 (en)	2003-04-29	Inhalation solution formulation with a tiotropium salt
AU2002221738A1 (en)	2002-07-18	Inhalative solution formulation containing a tiotropium salt
SE0001648L (en)	2000-11-19	Respirator with a breathing circuit
DK1267974T3 (en)	2005-08-01	inhaler
SE9903426D0 (en)	1999-09-22	Inhalation device
SE9903427D0 (en)	1999-09-22	Inhalation device
SE9903428D0 (en)	1999-09-22	Inhalation device
SE9902671D0 (en)	1999-07-12	Inhalation device
SE9903429D0 (en)	1999-09-22	Inhalation device
ES1046532Y (en)	2001-06-01	PERFECTED INHALER
UA8791S (en)	2004-05-17	CHILDREN'S KNITTED SUIT